Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Clinical trial NCT04018599 · COMPLETED

Trial details

NCT number: NCT04018599
Sponsor: Fresenius Kabi SwissBioSim GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis Polyarticular Juvenile Idiopathic Arthritis Psoriatic Arthritis Ankylosing Spondylitis Crohn Disease Ulcerative Colitis Plaque Psoriasis Pediatric Plaque Psoriasis Pediatric Crohns Disease Hidradenitis Suppurativa Non-infectious Uveitis

Start date: 2019-07-15
Primary completion: 2020-03-17
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.